This Stanford Medicine study clarifies the underlying biology of high-grade serous ovarian cancer and could help lead to future therapies.
Stanford pain expert Beth Darnall discusses her clinical trials on methods to taper opioid doses for patients with chronic pain.
Even adults who are not considered "high-risk" should be tested to reduce deaths and improve cure rates, new Stanford Health Policy research suggests.
Abdominal aortic aneurysms may be caused by the overexpression of a "don't eat me" protein that blocks the disposal of dead and dying cells.
Douglas Lowy, deputy director of the National Cancer Institute, recently spoke at Stanford Medicine.
A new study suggests that a blood test following exercise may be a good way to differentiate between people who have ME/CFS and people who don't.
Several severely depressed patients were helped by a new, experimental form of transcranial magnetic stimulation developed by Stanford Medicine researchers.
A new study led by the late Ben Barres suggests that rogue astrocytes may be involved in memory loss in otherwise healthy older brains.
Stanford researchers led work on a possible cancer vaccine that involves injecting two immune-stimulating agents directly into solid tumors.
A conversation about a molecule called Ino80 led to findings that could help researchers develop therapies for a rare genetic disease of the heart muscle.
Fifty years after the first adult heart transplant in the U.S., the event featured doctors who've contributed to the development of heart transplantation.
The study's finding is likely to translate into an increase in the number of acute-stroke patients receiving thrombectomies -- and likely save lives.
Stanford chemist Lynette Cegelski and her team discovered a new form of bacterial cellulose, a finding that could shed light on new ways to fight bacterial infections.
There are easy ways to test for HIV, and there are reliable ways, but easy and reliable? That's hard to come by — but perhaps not for long.
Stanford's Ruth O'Hara discusses research on worrying and its impact on cognition, memory and effective disorders in older adults.
This is the fifth in a series of blog posts, by Randall Stafford, MD, PhD discussing prediabetes and Type 2 diabetes.